PCOS Testing in Singapore: Where to Go, What It Costs, and the Panel That Gets Skipped

If you've sat in a ten-minute polyclinic consult, described months of irregular periods, and walked out with a prescription for the pill and no blood test, you weren't imagining the speed of it. That is roughly the default path in Singapore for PCOS — now renamed PMOS, after a Lancet consensus in May 2026 (read what changed). The pill is a reasonable symptom tool. It is not a workup. And the part of PMOS that the rename was meant to foreground — the metabolic half — is the part a fast consult tends to skip.

This is a navigation guide, not a panel explainer. We've written the full breakdown of which markers matter and why in lean PMOS. Here we're answering the more practical Singapore questions: where to actually go, what each route costs, and how to make sure the right tests get ordered rather than trimmed.

Why the standard workup misses the metabolic half

PMOS is, at its core, a whole-body metabolic condition driven by insulin resistance — not an ovary problem (the whole-body map). The diagnostic standard most Singapore clinicians use is the Rotterdam criteria, which need two of three: irregular cycles, signs of high androgens, or polycystic ovaries on ultrasound. None of those three require an insulin or SHBG result. So a diagnosis can be made — correctly — while the metabolic engine underneath goes unmeasured.

That gap matters more for Asian women, not less. A 2024 NUS cohort found roughly 27% of Asian women with PMOS show a low-SHBG pattern, meaning more active testosterone than a "normal" total testosterone suggests. And European-derived reference ranges tend to under-flag insulin resistance in Asian bodies, where it can sit in the so-called normal band. A workup that stops at total testosterone and a glucose reading can miss both.

The panel worth asking for by name

You don't need an exotic list. The additions that turn a basic workup into a real metabolic one are short, inexpensive, and clinically defensible:

• SHBG and free testosterone (or the calculated free androgen index)
• Fasting insulin, paired with fasting glucose to calculate HOMA-IR
• HbA1c, which can move before fasting glucose does

That's the core. The full reasoning for each — and how to frame the request so it reads as sensible rather than fringe — is in our lean PMOS guide. Bring it by name.

Your three routes

Polyclinic first. This is the subsidised entry point, and for most people the cheapest — a subsidised consult for citizens is on the order of S$15–20. A polyclinic GP can order baseline bloods and, if needed, refer you onward to a public specialist. The catch is throughput: consults are short, and the metabolic add-ons above are not automatic — you have to ask.

Subsidised specialist (KKH, NUH, SGH). A polyclinic or GP referral, including under CHAS, routes you to a restructured-hospital specialist at subsidised rates — citizens get up to 70% off through means-tested subsidies, so a first consult typically lands around S$30–60. The trade-off is the wait: in 2024 the median for a subsidised referral to a public specialist clinic was about a month, and non-urgent conditions like PMOS can sit at the longer end.

Private. Faster and longer consults, at private prices: a first specialist consult runs roughly S$120–350 (gynaecologist) to S$150–350 (endocrinologist), a hormone panel around S$150–350 depending on how many markers, and a pelvic ultrasound roughly S$150–350. You're paying for time and speed, not better tests — the same bloods are available on the subsidised track.

Endocrinologist or gynaecologist?

Both can diagnose PMOS. The distinction is one of lens. A gynaecologist's focus is the reproductive organs and cycle regulation. An endocrinologist's is the whole hormonal and metabolic system — which is exactly where the rename points. If your concern is metabolic (weight that won't shift, insulin resistance, family history of diabetes), the endocrine lens tends to fit the condition better. If it's primarily fertility or cycle management, a gynaecologist is a natural start. Plenty of women see both over time.

What subsidies actually cover

Two honest caveats. CHAS subsidises GP visits and referrals, but the subsidy lands on the consultation more than on a long list of optional diagnostic bloods. And MediSave generally cannot be used for routine outpatient diagnostic tests — its outpatient use is largely reserved for conditions on the MOH chronic-disease list, which PMOS is not automatically on. The practical read: budget for the metabolic panel as a likely out-of-pocket add-on, and ask the clinic directly what your visit covers before assuming.

Coming prepared: how to ask

A short consult goes better when you arrive specific. Rather than "can you run some hormone tests," try naming the markers and the reason: "Given the irregular cycles and the rename to PMOS, can we check SHBG, free testosterone, and fasting insulin alongside the usual?" That single sentence does two things — it shows you understand the condition is metabolic, and it gives your doctor concrete, orderable items to work from rather than an open-ended ask. Singapore research on PCOS care has noted that women here often navigate the condition without structured metabolic support; arriving with the panel named is one small way to close that gap yourself.

A normal BMI doesn't rule PMOS out. It shows up at normal body weight more often than the textbooks suggest, and for Asian patients the relevant thresholds sit lower — around 23 and 25, not the WHO 25 and 30 — so it's worth raising if a normal weight is being used to reassure you.

Where to start

If you're not sure whether your symptoms point this way at all, our free 5-minute assessment shows you a result without asking for anything in return — a useful thing to read before you book, so you walk in knowing what to ask for. And once the workup is sorted, the day-to-day is where it plays out: for the Singapore version of eating well, see eating for PMOS at the hawker centre.

Citations

• Teede HJ, et al. Renaming polycystic ovary syndrome. The Lancet, 2026 May 12. (Consensus statement.)
• Sex hormone-binding globulin and metabolic phenotype in Asian women with PCOS. NUS cohort, 2024. (Observational cohort.)
• International evidence-based guideline for the assessment and management of polycystic ovary syndrome, 2023. (Clinical guideline — Rotterdam criteria.)
• Barriers and enablers to implementing lifestyle management for women with PCOS in Singapore. (Qualitative study, PMC4910192.)
• Ministry of Health Singapore — Subsidies for Specialist Outpatient Care at Public Healthcare Institutions (Singapore citizens: up to 70% means-tested subsidy).
• Ministry of Health Singapore — Wait time for primary-care referral to public hospital Specialist Outpatient Clinics (median ~35 days for subsidised patients, 2024).
• SingHealth Polyclinics — Charges and Payment (polyclinic consultation fees). Private consult, panel, and ultrasound ranges are from published clinic fee schedules and vary by provider.